Levocetirizine + Montelukast Suspension PCD Pharma Franchise in Maharashtra

Levocetirizine 2.5mg + Montelukast 4mg Syrup Manufacturer in Uttarakhand

Best PCD Company for Antiallergic Suspension in Gujarat

Levocetirizine + Montelukast Syrup Third Party Manufacturer in Punjab

Levocetirizine Montelukast Suspension Supplier in West Bengal
Export Quality Levocetirizine + Montelukast Suspension from India

Home/Products /levocetirizine-2-point-5mg-montelukast-4mg-syrup

About the Product

Description


Monclip LC Suspension contains Levocetirizine (2.5 mg) and Montelukast (4 mg), a combination of an antihistamine and a leukotriene receptor antagonist. Levocetirizine helps block histamine to relieve symptoms of allergies, while Montelukast reduces inflammation in the airways by blocking leukotrienes.

It helps in the treatment of allergic rhinitis, sneezing, runny nose, nasal congestion, watery eyes, and mild asthma symptoms, especially in children.

May cause mild drowsiness, dry mouth, headache, or abdominal discomfort. Rarely, behavioral changes or allergic reactions may occur.

Indicated for children suffering from seasonal or perennial allergic rhinitis, allergic conjunctivitis, and mild asthma-related symptoms. Use under pediatric supervision.

Use only as prescribed by a pediatrician. Shake well before use. Inform your doctor about any existing medical conditions or ongoing medications.

Store below 25°C in a cool, dry place, away from direct sunlight. Keep out of reach of children. Use within the recommended period after opening.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Levocetirizine 2.5mg + Montelukast 4mg Syrup in the PCD pharma franchise market?

Levocetirizine + Montelukast Syrup is used for allergic rhinitis, seasonal allergies, asthma-related symptoms, and respiratory tract inflammation. It is a strong respiratory and pediatric segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this syrup in their product range?

Medical distributors and wholesalers can benefit from steady demand in pediatric clinics, ENT practices, general physicians, and respiratory care prescriptions. It is widely used for long-term allergy control and asthma-related allergic conditions, ensuring consistent prescription flow.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory and anti-allergic formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this respiratory product?

Wholesalers and medical agencies benefit from strong seasonal demand, pediatric prescriptions, repeat usage, and high retail movement in allergy and respiratory segments when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this syrup?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.